Department of Radiology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima City, 890-8544, Japan,
Eur Radiol. 2014 Apr;24(4):857-65. doi: 10.1007/s00330-013-3086-5. Epub 2013 Dec 20.
We aimed to develop and assess the efficacy of a liver function index that combines liver enhancement and liver volume to standard liver volume (LV/SLV) ratio on gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MRI.
In all, 111 patients underwent a Gd-EOB-DTPA-enhanced MRI, including T1 mapping, before and 20 min after Gd-EOB-DTPA administration. We calculated the following Gd-EOB-DTPA-enhanced MRI-based liver function indices: relative enhancement of the liver, corrected enhancement of the liver-to-spleen ratio, LSC_N20, increase rate of the liver-to-muscle ratio, reduction rate of T1 relaxation time of the liver, ΔR1 of the liver and K Hep; the indices were multiplied by the LV/SLV ratio. We calculated the correlations between an indocyanine green (ICG) clearance and the Gd-EOB-DTPA-enhanced MRI-based liver function indices multiplied by the LV/SLV ratio, by using Pearson correlation analysis.
There were significant correlations between all Gd-EOB-DTPA-enhanced MRI-based liver function indices and ICG clearance (r = -0.354 to -0.574, P < 0.001). All Gd-EOB-DTPA-enhanced MRI-based liver function indices multiplied by the LV/SLV ratio (r = -0.394 to -0.700, P < 0.001) were more strongly correlated with the ICG clearance than those without multiplication by the LV/SLV ratio.
Gd-EOB-DTPA-enhanced MRI-based liver function indices that combine liver enhancement and the LV/SLV ratio may more reliably estimate liver function.
• Gd-EOB-DTPA-enhanced MRI is useful for assessing liver function. • Liver enhancement on Gd-EOB-DTPA-enhanced MRI correlates with indocyanine green (ICG) clearance. • Liver volume to standard liver volume (LV/SLV) ratio correlates with ICG clearance. • Liver enhancement and LV/SLV ratio help to estimate liver function.
我们旨在开发和评估一种结合肝增强和肝体积与标准肝体积(LV/SLV)比值的肝功能指数,用于钆塞酸二钠(Gd-EOB-DTPA)增强磁共振成像。
共 111 例患者在 Gd-EOB-DTPA 给药前和给药后 20 分钟进行 Gd-EOB-DTPA 增强 MRI,包括 T1 映射。我们计算了以下基于 Gd-EOB-DTPA 增强 MRI 的肝功能指数:肝相对增强,肝脾增强比值校正,LSC_N20,肝肌肉比值增长率,肝 T1 弛豫时间降低率,肝 ΔR1 和 K Hep;将这些指数乘以 LV/SLV 比值。我们通过 Pearson 相关分析,计算了 ICG 清除率与乘以 LV/SLV 比值的 Gd-EOB-DTPA 增强 MRI 相关肝功能指数之间的相关性。
所有 Gd-EOB-DTPA 增强 MRI 相关的肝功能指数与 ICG 清除率均有显著相关性(r = -0.354 至-0.574,P < 0.001)。乘以 LV/SLV 比值的所有 Gd-EOB-DTPA 增强 MRI 相关肝功能指数(r = -0.394 至-0.700,P < 0.001)与 ICG 清除率的相关性均强于未乘以 LV/SLV 比值的相关性。
结合肝增强和 LV/SLV 比值的 Gd-EOB-DTPA 增强 MRI 相关肝功能指数可能更可靠地评估肝功能。
Gd-EOB-DTPA 增强 MRI 可用于评估肝功能。
Gd-EOB-DTPA 增强 MRI 上的肝增强与吲哚菁绿(ICG)清除率相关。
肝体积与标准肝体积(LV/SLV)比值与 ICG 清除率相关。
肝增强和 LV/SLV 比值有助于评估肝功能。